BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...the m2000 system from Abbott Laboratories (NYSE:ABT); Panther Fusion System from Hologic Inc. (NASDAQ:HOLX); GeneXpert Infinity...
BioCentury | Mar 21, 2020
Management Tracks

Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

...Epizyme Inc. (NASDAQ:EPZM) hired Jeffery Kutok as CSO. He was EVP and CSO of Infinity Pharmaceuticals Inc. (NASDAQ:INFI...
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

...roles of EVP of corporate development at Biogen Inc. (NASDAQ:BIIB); founder, chairman and CEO of Infinity Pharmaceuticals Inc....
...before that CBO at Millennium Pharmaceuticals Inc., which Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) acquired. At Infinity...
BioCentury | Sep 16, 2019
Company News

Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian

...as its first CMO and Allan Reine as its first CFO. Agresta was CMO at Infinity Pharmaceuticals Inc....
BioCentury | Aug 23, 2019
Company News

Management tracks: Erasca, Frequency, PerkinElmer, CytomX, Infinity and more

...has stepped down as SVP and CMO. The cancer company plans to seek a successor. Infinity Pharmaceuticals Inc....
...He was commercial excellence leader at GE Healthcare. Jonathan Block, Associate Editor CytomX Therapeutics Inc. Erasca Inc. Frequency Therapeutics Inc. Infinity Pharmaceuticals Inc. PerkinElmer...
BioCentury | Jan 28, 2019
Company News

Management tracks: Ironwood reveals board for new companies

...cyclase (sGC) pipeline, while Ironwood focuses on its gastrointestinal business. Acorda Therapeutics Inc. (NASDAQ:ACOR) and Infinity Pharmaceuticals Inc....
BioCentury | Jan 23, 2019
Company News

Vertex fires COO Smith for personal misconduct

...Therapeutics Inc. (NASDAQ:ACOR) and Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Acorda President and CEO Ron Cohen declined to comment. Infinity...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Oct 19, 2018
Financial News

Verastem raises $150M in notes offering

...Grants CSPC Rights to Copiktra in China" ). Verastem has worldwide rights to Copiktra from Infinity Pharmaceuticals Inc....
BioCentury | Oct 6, 2018
Finance

Large cap comeback

...vestronidase alfa to treat mucopolysaccharidosis type VII (MPS VII; Sly syndrome) Verastem Inc. (NASDAQ:VSTM) / Infinity Pharmaceuticals Inc....
Items per page:
1 - 10 of 372
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...the m2000 system from Abbott Laboratories (NYSE:ABT); Panther Fusion System from Hologic Inc. (NASDAQ:HOLX); GeneXpert Infinity...
BioCentury | Mar 21, 2020
Management Tracks

Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

...Epizyme Inc. (NASDAQ:EPZM) hired Jeffery Kutok as CSO. He was EVP and CSO of Infinity Pharmaceuticals Inc. (NASDAQ:INFI...
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

...roles of EVP of corporate development at Biogen Inc. (NASDAQ:BIIB); founder, chairman and CEO of Infinity Pharmaceuticals Inc....
...before that CBO at Millennium Pharmaceuticals Inc., which Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) acquired. At Infinity...
BioCentury | Sep 16, 2019
Company News

Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian

...as its first CMO and Allan Reine as its first CFO. Agresta was CMO at Infinity Pharmaceuticals Inc....
BioCentury | Aug 23, 2019
Company News

Management tracks: Erasca, Frequency, PerkinElmer, CytomX, Infinity and more

...has stepped down as SVP and CMO. The cancer company plans to seek a successor. Infinity Pharmaceuticals Inc....
...He was commercial excellence leader at GE Healthcare. Jonathan Block, Associate Editor CytomX Therapeutics Inc. Erasca Inc. Frequency Therapeutics Inc. Infinity Pharmaceuticals Inc. PerkinElmer...
BioCentury | Jan 28, 2019
Company News

Management tracks: Ironwood reveals board for new companies

...cyclase (sGC) pipeline, while Ironwood focuses on its gastrointestinal business. Acorda Therapeutics Inc. (NASDAQ:ACOR) and Infinity Pharmaceuticals Inc....
BioCentury | Jan 23, 2019
Company News

Vertex fires COO Smith for personal misconduct

...Therapeutics Inc. (NASDAQ:ACOR) and Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Acorda President and CEO Ron Cohen declined to comment. Infinity...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Oct 19, 2018
Financial News

Verastem raises $150M in notes offering

...Grants CSPC Rights to Copiktra in China" ). Verastem has worldwide rights to Copiktra from Infinity Pharmaceuticals Inc....
BioCentury | Oct 6, 2018
Finance

Large cap comeback

...vestronidase alfa to treat mucopolysaccharidosis type VII (MPS VII; Sly syndrome) Verastem Inc. (NASDAQ:VSTM) / Infinity Pharmaceuticals Inc....
Items per page:
1 - 10 of 372